nulojix 250mg powder for concentrate for solution for infusion vials
bristol-myers squibb pharmaceuticals ltd - belatacept - powder for solution for infusion - 250mg
nulojix 250 mg
bristol-myers squibb (israel) limited - belatacept 25 mg/ml - powder for concentrate for infusion - belatacept - nulojix, in combination with corticosteroids and mycophenolic acid (mpa), is indicated for prophylaxis of graft rejection in adults receiving a renal transplant. it is recommended to add an interleukin (il)-2 receptor antagonist for induction therapy to this belatacept-based regimen
nulojix
bristol-myers squibb pharma eeig - belatacept - graft rejection; kidney transplantation - immunosuppressants - nulojix, in combination with corticosteroids and a mycophenolic acid (mpa), is indicated for prophylaxis of graft rejection in adult recipients of a renal transplant.
nulojix 250 mg lyophilisate for solution for injection
bristol-myers squibb - belatacept - lyophilisate for solution for injection - 250 mg